Amrize (AMRZ) Cash & Equivalents (2024 - 2026)

Amrize has reported Cash & Equivalents for 3 years, with the latest figure at $1.1 billion in Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $1.9 billion, up 21.26% from the prior year.
• Cash & Equivalents fell to $1.1 billion in Q1 2026 per AMRZ's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $1.9 billion in Q4 2025 and troughed at $601.0 million in Q2 2025.
• A 3-year average of $1.2 billion and a median of $1.1 billion in 2026 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 21.26% in 2025, down 21.26% in 2025.
• Over 3 years, Cash & Equivalents stood at $1.6 billion in 2024, then rose by 21.26% to $1.9 billion in 2025, then plunged by 42.82% to $1.1 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.1 billion, $1.9 billion, and $826.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.